Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.

Detalles Bibliográficos
Autores principales: Schluger, Neil, Karunakara, Unni, Lienhardt, Christian, Nyirenda, Thomas, Chaisson, Richard
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062480/
https://www.ncbi.nlm.nih.gov/pubmed/17988170
http://dx.doi.org/10.1371/journal.pmed.0040302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062480/
https://www.ncbi.nlm.nih.gov/pubmed/17988170
http://dx.doi.org/10.1371/journal.pmed.0040302

Ejemplares similares